David Cordani sold $8.2M of CI
Chairman & CEO at Cigna Group. 26,527 shares at an average of $308.12, traded Mar 3, 2025, filed Mar 4, 2025.
Score components
- +25RoleCEO
- +25Trade size$8.2M at market
- +5Share of holdings soldSold 17% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.1%, 3m +1.9%, 6m -1.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-002922, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | AGrant or award Common Stock, $.01 Par Value10b5-1 | +49,437 | $0.00 | $0 | 170,783 | Mar 4, 2025 |
| Feb 28, 2025 | AGrant or award Common Stock, $.01 Par Value10b5-1 | +11,117 | $0.00 | $0 | 181,900 | Mar 4, 2025 |
| Feb 28, 2025 | FTax withholding Common Stock, $.01 Par Value10b5-1 | -4,696 | $305.86 | $1.4M | 177,204 | Mar 4, 2025 |
| Feb 28, 2025 | FTax withholding Common Stock, $.01 Par Value10b5-1 | -22,910 | $305.86 | $7.0M | 154,294 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -26,527 | $308.12 | $8.2M | 127,767 | Mar 4, 2025 |
| Feb 28, 2025 | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +39,476 | $0.00 | $0 | 39,476 | Mar 4, 2025 |
Related signals
Other insiders at Cigna Group and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Cigna Group | Everett Neville See Remarks | $175k 617 shares | -11% | |
| 16Weak | Cigna Group | Nicole S Jones See Remarks | $749k 2,677 shares | -9% | |
| 15Weak | Cigna Group | Nicole S Jones See Remarks | $5.4M 19,436 shares | -42% | |
| 23Weak | CIsell Cigna Group | Jamie G Kates Chief Accounting Officer | $268k 899 shares | -28% | |
| 35Weak | Cigna Group | David Cordani Chairman & CEO | $59M 201,878 shares | -85% | |
| 23Weak | Cigna Group | Nicole S Jones See Remarks | $667k 2,307 shares | -7% | |
| 26Weak | Cigna Group | Everett Neville See Remarks | $497k 1,719 shares | -23% | |
| 64Notable | CIbuy Cigna Group | David Cordani Chairman & CEO | $1000k 4,134 shares | +3% | |
| 5Weak | Cigna Group | Brian C Evanko See Remarks | $1.6M 5,368 shares | -9% | |
| 25Weak | Cigna Group | Nicole S Jones See Remarks | $8.6M 28,526 shares | -53% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.